Hjem › Hemofili › Pennsylvania
Kliniske studier for Hemofili i Pennsylvania
6 studier for Hemofili søker deltakere på steder i Pennsylvania.
Byer i Pennsylvania
Offisiell studietekst (engelsk)
Safety and Effectiveness of Giroctocogene Fitelparvovec or Fidanacogene Elaparvovec in Patients With Hemophilia A or B Respectively
- The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
- The Childrens Hospital of Philadelphia Division of Hematology, Philadelphia
RekruttererFase 3
Alder 18 og eldre · Menn · Oppdatert 2. okt. 2026 · NCT05568719A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A
- Penn State MS Hershey Med Ctr, Hershey
- St Christopher Hosp for Child, Philadelphia
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 64 · Menn · Oppdatert 18. sep. 2026 · NCT07220564ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
- Children's Hospital of Philadelphia, Philadelphia
- Penn Comprehensive Hemophilia and Thrombophilia Program/Hospital of the University of Pennsylvania, Philadelphia
- St. Christopher's Hospital for Children, Philadelphia
- og 1 flere
RekruttererObservasjonsstudie
Alle aldre · Alle kjønn · Oppdatert 17. aug. 2026 · NCT04398628A Study of Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of SR604 in Two Participants Groups (Part A: Healthy Participants, and Part B: Participants With Hemophilia A or Hemophilia B or Factor VII Deficiency)
- Penn State Milton S Hershey Medical Center Pediatrics, Hershey
- Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program, Philadelphia
RekruttererFase 1Frivillige helsepersonell ønskes velkommen
Alder 18 til 60 · Alle kjønn · Oppdatert 2. jul. 2026 · NCT06349473Open-Label Extension Study of Marstacimab in Hemophilia Participants With or Without Inhibitors
- The Feinstein Institutes for Medical Research, Philadelphia
RekruttererFase 3
Alder 1 til 74 · Menn · Oppdatert 1. jul. 2026 · NCT05145127Emicizumab for Severe Von Willebrand Disease (VWD) and VWD/Hemophilia A
- Penn State College of Medicine, Hershey
RekruttererFase 1
Alder 0 til 90 · Alle kjønn · Oppdatert 3. apr. 2026 · NCT05500807Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.